|
Dr. Osamu OkudaRepresentative Director, President & CEO In charge of Audit Department
- Profile
-
Date of Birth April 5, 1963
- 1987 Joined the Company
- 2008 General Manager of Lifecycle Management Dept. II
- 2009 General Manager of Lifecycle Management Dept. II and Head of Lifecycle
- 2011 President of Roche Products (Ireland) Limited
- 2013 General Manager of Oncology Unit, Marketing & Sales Division
- 2014 Vice President, General Manager of Oncology Unit, Marketing & Sales Division
- 2015 Vice President, General Manager of Corporate Planning Department
- 2017 Executive Vice President, General Manager of Corporate Planning Department
- 2018 Executive Vice President, Co-Head of Project & Lifecycle Management Unit
- 2020 Representative Director, President & COO
- 2021 Representative Director, President & CEO (to present)
|
 |
Iwaaki TaniguchiDirector, Executive Vice President & CFO Head of Finance Supervisory Division
- Profile
-
Date of Birth December 4, 1966
- 1989 Joined The Long-Term Credit Bank of Japan, Limited (currently SBI Shinsei Bank, Limited)
- 2004 Joined Takeda Pharmaceutical Company Limited (“Takeda”)
- 2013 General Manager of Corporate Finance Department of Takeda
- 2015 General Manager of Finance Management Department of Takeda
- 2017 Joined Recruit Holdings Co., Ltd.
Corporate Executive Officer (Responsible for Finance) of Recruit Holdings Co., Ltd.
- 2018 Corporate Executive Officer (Responsible for Finance), of Recruit Holdings Co., Ltd. and Director of Recruit Co., Ltd.
- 2022 Joined the Company
Senior Vice President, Head of Finance & Accounting Department
- 2023 Senior Vice President
Head of Finance Supervisory Div. (to present) Head of Finance & Accounting Department
- 2024 Director, Executive Vice President & CFO (to present)
|
 |
Dr. Hitoshi IikuraDirector, Executive Vice President
Head of Translational Research Division
- Profile
-
Date of Birth February 26, 1970
- 2000 Joined the Company
- 2017 Head of Medicinal Chemistry Research Department
- 2021 Head of Research Division
- 2022 Vice President, Head of Research Division
- 2024 Vice President, Head of Translational Research Division
|
OutsideIndependent
|
Dr. Mariko Y Momoi
Professor Emeritus of Jichi Medical University
Invited Professor of School of Medicine, Shinshu University
Regent of Tokyo Medical University (part-time)
- Profile
-
Date of Birth February 24, 1948
- 1994 Head of Department of Pediatrics, Jichi Medical University
- 2006 Director of Jichi Children’s Medical Center Tochigi
- 2010 Dean of School of Medicine, Jichi Medical University
- 2012 Visiting Professor of School of Medicine, Shinshu University
- 2013 Professor Emeritus of Jichi Medical University (to present)
Vice President of International University of Health and Welfare
- 2014 Director of Japanese Medical Specialty Board (part-time)
- 2015 Vice President of International University of Health and Welfare and Head of IUHW Hospital
- 2017 Chief Medical Officer of Ryoumou Seishi Ryogoen, Kiryu Ryoiku Futabakai Social Welfare Corporation
- 2018 Regent of Tokyo Medical University (part-time) (to present)
- 2020 Director of the Company (to present)
- 2024 Invited Professor of School of Medicine, Shinshu University (to present)
|
OutsideIndependent
|
Dr. Fumio Tateishi
Honorary Advisor of OMRON Corporation
- Profile
-
Date of Birth July 6, 1949
- 1975 Joined Tateisi Electronics Co. (currently OMRON Corporation)
- 1997 Director of OMRON Corporation (“OMRON”)
- 1999 Managing Executive Officer of OMRON
- 2001 Senior General Manager, Corporate Strategic Planning HQ of OMRON
- 2003 Executive Officer and Executive Vice President of OMRON
President, Industrial Automation Business Company of OMRON
- 2008 Director and Executive Vice Chairman of OMRON
- 2013 Chairman of the Board of OMRON
- 2023 Director of the Company (to present)
Honorary Advisor of OMRON (to present)
|
OutsideIndependent
|
Hideo Teramoto
President of Dai-ichi Life Research Institute, Inc. Outside Director of Imperial Hotel, Ltd.
- Profile
-
Date of Birth May 20,1960
- 1983 Joined The Dai-ichi Mutual Life Insurance Company
- 2012 Director, Managing Executive Officer, Deputy Chief General Manager of Group Management Headquarters, and General Manager of Corporate Planning Department of The Dai-ichi Life Insurance Company, Limited. (“DLI”)
- 2013 Director, Managing Executive Officer, and Deputy Chief General Manager of Group Management Headquarters of DLI
- 2015 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of DLI
- 2016 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of Dai-ichi Life Holdings, Inc. (“DLH”)
Director and Senior Managing Executive Officer of DLI
- 2017 Director of DLH
Representative Director and Vice Chairman of DLI
- 2020 Director, Vice Chairman, and General Manager of Innovation Strategy Unit of DLH
- 2021 Representative Director, Vice Chairman, and Executive Officer of DLH
- 2022 Director of DLH
President of Dai-ichi Life Research Institute, Inc. (to present)
- 2023 Director of the Company (to present)
Outside Director of Imperial Hotel, Ltd. (to present)
|
 |
Thomas Schinecker
Roche Group, CEO
- Profile
-
Date of Birth April 23, 1975
- 2003 Joined Roche Group
- 2005 Head of Marketing and Sales of Roche Diagnostics Austria
- 2008 General Manager of Roche Diagnostics Sweden
- 2011 Lifecycle Leader Sequencing Solutions of Roche Diagnostics
- 2013 General Manager of Roche Diagnostics Germany
- 2018 Global Head of Roche Diagnostics Centralised and Point of Care Solutions of Roche Diagnostics
- 2019 CEO of Roche Diagnostics
Member of the Corporate Executive Committee (to present)
- 2023 CEO ad interim of Roche Pharma
CEO of Roche Group (to present)
- 2025 Director of the Company (to present)
|
 |
Teresa A. Graham
CEO of Roche Pharmaceuticals Member of the Roche Corporate Executive Committee
- Profile
-
Date of Birth December 30, 1973
- 2005 Joined Genentech, Inc. as Product Manager
- 2010 Sales Manager of Genentech
- 2011 Marketing Director of Genentech
- 2013 Senior Director, Field Reimbursement Management of Genentech
- 2015 Lifecycle Leader, ACTEMRA of Roche
- 2017 Vice President, Rheumatology / Nephrology of Genentech
- 2018 Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lung & GI Oncology Sales of Genentech
- 2019 Head of Global Product Strategy of Roche Pharmaceuticals
- 2023 CEO of Roche Pharmaceuticals
Member of the Corporate Executive Committee (to present)
Director of the Company (to present)
|
 |
Boris L. Zaïtra
Head of Corporate Business Development of Roche
Member of the enlarged Corporate Executive Committee
- Profile
-
Date of Birth April 24, 1972
- 1995 Mergers & Acquisitions, Associate of JP Morgan
- 1999 Duke Street Capital, Partner
- 2005 Head of Mergers & Acquisitions, Corporate Vice-President of Airbus Group
- 2012 Head of Group Business Development/M&A of Roche
- 2024 Head of Corporate Business Development of Roche (to present)
Member of the enlarged Corporate Executive Committee (to present)
- 2025 Director of the Company (to present)
|